ecancermedicalscience

Case Report

Pregnant with metastatic neuroendocrine tumour of the ovary: what now?

3 Jan 2012
B Pistilli, CM Grana, N Fazio, A Cavaliere, ME Ferrari, L Bodei, SM Baio, G Scambia, G Paganelli, FA Peccatori

Neuroendocrine tumours (NET) are a heterogeneous group of neoplasms commonly occurring in the gastrointestinal tract or lungs but can occur in other regions. Primary ovarian NET account for 5% of all NET and 0.1% of all ovarian malignancies. In metastatic disease, the therapeutic goal is to extend survival and to improve quality of life. As these tumours express somatostatin receptors, somatostatin analogues are frequently used to control symptoms. Here we present a case of a pregnant woman with an ovarian NET with liver metastases and carcinoid syndrome who was treated with the somatostatin analogue, Octreotide LAR. We also summarize reported data of the use of somatostatin analogues during pregnancy.

Related Articles

Pambinkavil Sivaraman Raji, Anitha Thomas, Vinotha Thomas, Anjana Joel, Dhanya Susan Thomas, Rachel G Chandy, Ajit Sebastian, Abraham Peedicayil
Solomon Kibudde, Awusi Kavuma, Bonny Abal, Moses Fredrick Katumba, Cissy Bangidde Namutale, Daniel Kanyike, Israel Luutu
Abideen A Olayiwola, Yusuf A Oshodi, Oluwarotimi I Akinola, Adekunbiola A Banjo, Kabiru A Rabiu, Ayokunle M Olumodeji
Beatrice P Mushi, Summaiya Haddadi, Alita Mrema, Jerry Ndumbalo, Nanzoke Mvungi, Msiba Selekwa, Julius Mwaiselage, Larry Akoko, Yona Ringo, Rohan Luhar, Rebecca DeBoer, Katherine Van Loon, Elia Mmbaga, Geoffrey C Buckle
Ally H Mwanga, Erick M Mbuguje, Jeanine Justiniano, Balowa Musa, Nashivai Kivuyo, Daniel W Kitua, Eva Uiso, Andrew Swallow, Edith Kimambo, Azza Naif, Deogratius B Mwanakulya, Swaleh Pazi, Advera Ngaiza, Seif Wibonela, Behnam Shaygi, Cameron E Gaskill